• News
  • SAN DIEGO
  • Finance

MEI Pharma announces $27.5 million private placement

San Diego-based MEI Pharma Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, has obtained commitments to purchase $27.5 million of its common stock and warrants in a private placement.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments
Subscribe Today!